News
We send the latest information from SMC Laboratories.
Drug Efficacy Study in the STAM™ Model Published in Cells
SMC is proud to announce that Cellaïon (BEL) has published the results of their study using our STAM&trad…
Drug Efficacy Study in the STAM™ Model Published in Gene
SMC is proud to announce that TSUMURA & CO. (JPN) has published the results of their study using our…
SMC participate The BioJapan Partnering!
We are pleased to announce that SMC Laboratories will be participating the BioJapan Partnering Event from…
Today, September 21th, is World Alzheimer’s Day!
We recently mentioned World Alzheimer's Month, including World Alzheimer's Day (Previous article), a…
The importance of the NAFLD activity score and the STAM™ model’s clinical relevance
In this issue, we would like to introduce the NAFLD activity score (NAS), which is one of the main endpoints u…
Introducing our Idiopathic Pulmonary Fibrosis (IPF) mouse model
The outbreak of COVID-19 causes a lot of complications and long-term harm to the patient, especially severe pu…
September is World Alzheimer’s Month!
In recognition of September 21st being World Alzheimer’s Day, why don’t we deepen our understandin…
SMC attend The Biotechgate Digital Partnering!
We are pleased to announce that SMC Laboratories will be virtually attending the Biotechgate Digital Partnerin…
SMC attend The 8th Taiwan-Japan Pharmaceutical Seminar/Business Matching!
We are pleased to announce that SMC Laboratories will be virtually attending the 8th Taiwan-Japan Pharmaceutic…
A study using liver samples from the STAM™ model published in PLOS ONE.
SMC is proud to announce that Institut de Recherches Servier (FRA) has published the results of their study us…